Small molecule inhibitors of USP1 deubiquitinating enzyme activity
Provided are small molecule inhibitors of ubiquitin specific protease 1 (USP1) activity and methods for their use in treating and characterizing cancers. The small molecule USP1 inhibitors of the invention are particularly useful in the treatment of cancers that are resistant to DNA cross-linking agents.
1. A pharmaceutical composition comprising:
a small molecule inhibitor of ubiquitin specific protease 1 (USP1) of Formula IV (527):
or a pharmaceutically acceptable salt thereof; and
a DNA cross-linking agent.
2. The pharmaceutical composition of claim 1 , further comprising a poly (adenosine diphosphate (ADP)-ribose) polymerase (PARP) inhibitor.
3. A pharmaceutical composition comprising:
a small molecule inhibitor of ubiquitin specific protease 1 (USP1) of Formula IV (527):
or a pharmaceutically acceptable salt thereof; and
a poly (adenosine diphosphate (ADP)-ribose) polymerase (PARP) inhibitor.